Project

Epi-Onco-Transcriptomic

Epitranscriptomic Landscape and Onco-transcriptomic/Proteomic Signature in Cancer Patients for Better Classification and Therapeutic Approaches

ITB Principal Investigator

Name

Epitranscriptomic Landscape and Onco-transcriptomic/Proteomic Signature in Cancer Patients for Better Classification and Therapeutic Approaches

Acronym

Epi-Onco-Transcriptomic

Location

Pisa

Start Date

2024

End Date

2026

Funder

PNRR-MCNT1

Partners

Ospedale Bambino Gesù, CNR IFC, Universita' di Catania

The main goal of this project is to explore the epitranscriptomic landscape and the onco-transcriptomic and proteomic signatures in cancer patients, aiming to improve tumor classification and develop more precise and personalized therapeutic strategies. The project integrates advanced molecular analyses to identify biological signatures that can guide clinical decision-making.